Is Intuitive Surgical a dominant monopoly — or a stock priced to perfection?

In this episode of The Intelligent Wealth Podcast, we take a deep dive into Intuitive Surgical (ISRG), the company behind the Da Vinci robotic surgery system, and analyse whether it’s still a compelling long-term investment.

With over 20 million procedures performed and a powerful competitive moat, Intuitive Surgical has built a dominant position in robotic-assisted surgery. But with a premium valuation and increasing competition, investors need to ask — is the growth already priced in?

In this video, we cover:

• Intuitive Surgical’s business model and competitive advantages
• The “razor and blade” recurring revenue model
• Why switching costs in healthcare are so powerful
• Financials: growth, margins, and balance sheet strength
• Key risks including valuation, competition, and supply chains
• The future of robotic surgery and AI in healthcare
• Would we personally invest? (2 vs 1 decision)

If you're interested in growth stocks, healthcare innovation, or long-term investing, this episode will give you a clear and balanced perspective.

Disclaimer:
The value of investments can rise as well as fall. You may not get back the full amount you invested. The views stated in this podcast are purely personal opinions, not advice. You should always consult a professional for investment advice.
--------------------

Music from #Uppbeat (free for Creators!):
https://uppbeat.io/t/abbynoise/night-...
License code: C4BIIEC6POGUQVDJ

Support the show

Disclaimer:
The value of investments can rise as well as fall. You may not get back the full amount you invested. The views stated in this podcast are purely personal opinions, not advice. You should always consult a professional for investment advice.
--------------------

Music from #Uppbeat (free for Creators!):
https://uppbeat.io/t/abbynoise/night-...
License code: C4BIIEC6POGUQVDJ